H. Lundbeck A/S

Pharmaceuticals

Company Summary

H. Lundbeck A/S is a biopharmaceutical firm that develops, manufactures, and sells medications for the treatment of psychiatric and neurological illnesses in Europe, North America, and other parts of the world. The company's headquarters are in Valby, Denmark, where it was founded in 1915.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

20
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0.3S12G7.3

Refinitiv

Overall ESG Rating :

55
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E52S61G49

Overall ESG Rating :

Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Temperature Rise :

CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned